NUQUADMEN Trademark

Trademark Overview

On Thursday, January 20, 2022, a trademark application was filed for NUQUADMEN with the United States Patent and Trademark Office. The USPTO has given the NUQUADMEN trademark a serial number of 97229442. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, August 20, 2024. This trademark is owned by Sanofi Pasteur Inc.. The NUQUADMEN trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines
nuquadmen

General Information

Serial Number97229442
Word MarkNUQUADMEN
Filing DateThursday, January 20, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesVaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi Pasteur Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSwiftwater, PA 18370
Party NameSanofi Pasteur Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSwiftwater, PA 18370

Trademark Events

Event DateEvent Description
Monday, January 24, 2022NEW APPLICATION ENTERED
Tuesday, January 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 2, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Sunday, February 6, 2022ASSIGNED TO LIE
Monday, June 27, 2022ASSIGNED TO EXAMINER
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 8, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, June 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, February 3, 2023SOU EXTENSION 1 FILED
Friday, February 3, 2023SOU EXTENSION 1 GRANTED
Thursday, August 17, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 17, 2023SOU EXTENSION 2 FILED
Thursday, August 17, 2023SOU EXTENSION 2 GRANTED
Wednesday, January 31, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 31, 2024SOU EXTENSION 3 FILED
Friday, February 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2024SOU EXTENSION 4 FILED
Tuesday, August 20, 2024SOU EXTENSION 4 GRANTED

Related Keywords

nuquadmen vaccines